Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

EU flag

EC approves CSL’s Andembry to prevent hereditary angioedema attacks

Approximately one in every 50,000 people worldwide are affected by the rare genetic disorder

- PMLiVE

Are we masters of our own health?

By Sarah Love

Mastering Outcome vs. Process Control in Remote Work – Building Company Culture Virtually

Struggling to manage your remote pharma teams effectively? Discover the power of outcome control. Learn how trusting your team to achieve results, their way, can lead to greater productivity and...

Impetus Digital

- PMLiVE

Pfizer granted FDA approval for Adcetris combination in large B-cell lymphoma

Up to 70% of patients with this form of non-Hodgkin lymphoma are diagnosed with advanced disease

- PMLiVE

FDA approves SpringWorks Therapeutics’ Gomekli to treat neurofibromatosis type 1

The rare genetic disorder affects approximately 100,000 people in the US

- PMLiVE

Eli Lilly and OliX partner to advance early-stage metabolic disease candidate

Metabolic-associated steatohepatitis is expected to affect over 19 million adults in the US by 2039

- PMLiVE

Novartis to expand cardiovascular pipeline with $3.1bn Anthos acquisition

The deal includes a candidate in phase 3 development to prevent complications of atrial fibrillation

- PMLiVE

Boehringer’s nerandomilast shows promise in phase 3 pulmonary fibrosis study

The company said it will now be submitting a new drug application for the candidate in this indication

- PMLiVE

CSL Behring announces four-year results for haemophilia B gene therapy Hemgenix

The genetic bleeding disorder affects an estimated one per every 19,283 male births in the US

- PMLiVE

AbbVie announces FDA approval of antibiotic combination for intra-abdominal infections

Antimicrobial resistance has been declared by WHO as one of the top ten threats to global health

- PMLiVE

Eli Lilly shares two-year results for Omvoh in active Crohn’s disease patients

Inflammatory bowel disease affects almost one in every 100 people in the US

- PMLiVE

Inizio appoints Jim Sage as president of Inizio Engage

Sage previously served as North American regional president for Pfizer's internal medicine business

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links